Tomography

Xoran Reaches 1000 Installations Worldwide

Retrieved on: 
Friday, February 18, 2022
XCAT, Patient, Ear, Cone beam computed tomography, TM, AI, CEO, CT scan, SBIR, Health, PACS, Anesthesia, National Cancer Institute, National, Temporal bone, Degenerative disease, OR, National Heart, Lung, and Blood Institute, Brain, ANN, Innovation, Neurosurgery, National Institutes of Health Clinical Center, NCI, Otorhinolaryngology, Federal Food, Drug, and Cosmetic Act, Robotics, FDA, Dermatology, Allergy, Critical Care Medicine (journal), Sale, CT, Tomography, NHLBI, 3D, NIH, 3D CT, Human skull symbolism, Nose, Research, University, Internet access, Ophthalmology, National Institute, Lung, Medical imaging, Medical device

ANN ARBOR, Mich., Feb. 18, 2022 /PRNewswire/ -- "Fast on the heels of Xoran's announcement of 900 MiniCAT™ and 50 VetCAT™ installations, we are proud to announce that Xoran has reached 1,000 system installations worldwide," says Misha Rakic, CEO of Xoran Technologies.

Key Points: 
  • ANN ARBOR, Mich., Feb. 18, 2022 /PRNewswire/ --"Fast on the heels of Xoran's announcement of 900 MiniCAT and 50 VetCAT installations, we are proud to announce that Xoran has reached 1,000 system installations worldwide," says Misha Rakic, CEO of Xoran Technologies.
  • As the pioneer and medical market leader in point-of-care cone beam CT since 2001, Xoran's team of domestic sales and customer service, along with international distributors, reaches 1,000 global device installs.
  • Xoran specifically designed its xCAT suite of products for use in the operating room and critical care unit.
  • With this progression, Xoran is working to demonstrate the potential of integrating surgical navigation capability into a mobile CT device.

Body Vision Medical Celebrates 1,000th Patient to Benefit from AI-Driven Lung Cancer Diagnostics Imaging

Retrieved on: 
Monday, November 29, 2021
Patient, Tomography, Adoption, CEO, Technology, CE, Lung cancer, Partnership, Diagnosis, Pulmonology, Physician, Biopsy, 3D, Survival, Fluoroscopy, Artificial intelligence, Vision, CT, Intelligence, Medical imaging

NEW YORK, Nov. 29, 2021 /PRNewswire/ -- Body Vision Medical , the pioneer in real-time artificial intelligence imaging for lung cancer diagnostics, announced that 1,000 patients have benefited fromits LungVisionsystem.Body Visionhas FDA and CE approvals andstarted selling commercially earlier this year.

Key Points: 
  • NEW YORK, Nov. 29, 2021 /PRNewswire/ -- Body Vision Medical , the pioneer in real-time artificial intelligence imaging for lung cancer diagnostics, announced that 1,000 patients have benefited fromits LungVisionsystem.Body Visionhas FDA and CE approvals andstarted selling commercially earlier this year.
  • We wouldn't have accomplished this milestone without our continued partnership withpulmonologists whounderstand that real-time imaging and visualconfirmation oftheir diagnostictool inside the lesion are keys to successfully acquiring diagnostic tissueduring lung biopsy," said Dorian Averbuch, CEO & Founder of Body Vision Medical.
  • Body Vision's mission is to make real-time imaging during diagnostic bronchoscopy an option for every lung patient.
  • Body Vision Medical is a medical device company specializing in artificial intelligence, real-time tomographic imaging, augmented fluoroscopy, and visual tool-in-lesion confirmation during diagnostic bronchoscopy.

Body Vision Medical Celebrates 1,000th Patient to Benefit from AI-Driven Lung Cancer Diagnostics Imaging

Retrieved on: 
Monday, November 29, 2021
Patient, Tomography, Adoption, CEO, Technology, CE, Lung cancer, Partnership, Diagnosis, Pulmonology, Physician, Biopsy, 3D, Survival, Fluoroscopy, Artificial intelligence, Vision, CT, Intelligence, Medical imaging

NEW YORK, Nov. 29, 2021 /PRNewswire/ -- Body Vision Medical , the pioneer in real-time artificial intelligence imaging for lung cancer diagnostics, announced that 1,000 patients have benefited from LungVision procedures.Body Visionhas FDA and CE approvals andstarted selling commercially earlier this year.

Key Points: 
  • NEW YORK, Nov. 29, 2021 /PRNewswire/ -- Body Vision Medical , the pioneer in real-time artificial intelligence imaging for lung cancer diagnostics, announced that 1,000 patients have benefited from LungVision procedures.Body Visionhas FDA and CE approvals andstarted selling commercially earlier this year.
  • We wouldn't have accomplished this milestone without our continued partnership withpulmonologists whounderstand that real-time imaging and visualconfirmation oftheir diagnostictool inside the lesion are keys to successfully acquiring diagnostic tissueduring lung biopsy," said Dorian Averbuch, CEO & Founder of Body Vision Medical.
  • Body Vision's mission is to make real-time imaging during diagnostic bronchoscopy an option for every lung patient.
  • Body Vision Medical is a medical device company specializing in artificial intelligence, real-time tomographic imaging, augmented fluoroscopy, and visual tool-in-lesion confirmation during diagnostic bronchoscopy.

Rigaku Acquires Life Science Imaging Equipment Manufacturer MILabs

Retrieved on: 
Tuesday, August 3, 2021
Medicine, Medical physics, Medical imaging, Neuroimaging, Medical specialties, Image processing, Nuclear medicine, Positron emission tomography, Tomography, Single-photon emission computed tomography, Emission computed tomography, Rigaku

Through this acquisition, Rigaku will expand its life sciences modality business globally by combining MILabs' multi-modality businesses, including PET (Positron Emission Tomography), SPECT (Single Photon Emission Computed Tomography), Optical Imaging, and CT (Computed Tomography) equipment for animals, with Rigaku's original X-ray imaging business for animals.

Key Points: 
  • Through this acquisition, Rigaku will expand its life sciences modality business globally by combining MILabs' multi-modality businesses, including PET (Positron Emission Tomography), SPECT (Single Photon Emission Computed Tomography), Optical Imaging, and CT (Computed Tomography) equipment for animals, with Rigaku's original X-ray imaging business for animals.
  • Through this acquisition, Rigaku aims to strengthen its pre-clinical imaging business within the life sciences field by incorporating MILabs' radiation imaging and optical imaging technologies, a new initiative for Rigaku, while simultaneously building its existing X-ray imaging business.
  • Rigaku believes that pre-clinical imaging will become increasingly important in the life sciences field.
  • Rigaku will actively enter the life science market and aim to develop this field as one of its core businesses by 2025.

Global Industrial Computed Tomography Market (2021 to 2028) - Size, Share & Trends Analysis Report - ResearchAndMarkets.com

Retrieved on: 
Friday, July 30, 2021
Photography, Technology, Hardware, Industrial computed tomography, Materials science, Microtechnology, Nondestructive testing, Reverse engineering, Tomography, Medicine, CT scan, Clinical medicine, Tests

The "Industrial Computed Tomography Market Size, Share & Trends Analysis Report by Offering (Equipment, Services), by Vertical (Oil & Gas, Electronics), by Application, by Region, and Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Industrial Computed Tomography Market Size, Share & Trends Analysis Report by Offering (Equipment, Services), by Vertical (Oil & Gas, Electronics), by Application, by Region, and Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
  • The global industrial computed tomography market size is expected to reach USD 765.8 million by 2028, registering a CAGR of 7.5% from 2021 to 2028.
  • Industrial computed tomography systems are increasingly being used for inspecting and testing the internal and external structure & design of various complex parts and components without destructing/disassembling the product.
  • Furthermore, assembly analysis is increasingly being done using the industrial computed tomography systems in the automotive industry that does not require the assembled systems to be disassembled for inspection.

Clinical Trial Imaging Market worth $1.4 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, July 27, 2021
Medical imaging, Medicine, Branches of biology, Medical physics, Tomography, Positron Corporation, Positron emission tomography, Whole-body nuclear scanning, MICAD

The services segment accounted for the largest share of the market, by product and service segment, in 2020

Key Points: 
  • The services segment accounted for the largest share of the market, by product and service segment, in 2020
    Based on product and service, the clinical trial imaging market is segmented into services and software.
  • The clinical trial imaging market is segmented into computed tomography, magnetic resonance imaging, ultrasound, positron emission tomography, X-ray, echocardiography and other modalities.
  • The major players operating in this clinical trial imaging market are ICON plc.
  • (US), anagram 4 clinical trials (Spain), Lyscaut Medical Imaging Company (Belgium), Calyx Group (UK), Bioseptive Inc. (Canada), ProScan Imaging LLC.

Clinical Trial Imaging Market worth $1.4 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, July 27, 2021
Medical imaging, Medicine, Branches of biology, Medical physics, Tomography, Positron Corporation, Positron emission tomography, Whole-body nuclear scanning, MICAD

The services segment accounted for the largest share of the market, by product and service segment, in 2020

Key Points: 
  • The services segment accounted for the largest share of the market, by product and service segment, in 2020
    Based on product and service, the clinical trial imaging market is segmented into services and software.
  • The clinical trial imaging market is segmented into computed tomography, magnetic resonance imaging, ultrasound, positron emission tomography, X-ray, echocardiography and other modalities.
  • The major players operating in this clinical trial imaging market are ICON plc.
  • (US), anagram 4 clinical trials (Spain), Lyscaut Medical Imaging Company (Belgium), Calyx Group (UK), Bioseptive Inc. (Canada), ProScan Imaging LLC.

Worldwide Computed Tomography Growth Opportunities to 2025 - COVID-19 Resulted in Postponement of Elective Surgeries

Retrieved on: 
Friday, July 23, 2021
Medical imaging, Radiology, Medicine, CT scan, Tomography, Health care, Health

DUBLIN, July 23, 2021 /PRNewswire/ -- The "Global Computed Tomography Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, July 23, 2021 /PRNewswire/ -- The "Global Computed Tomography Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.
  • An estimated 375 million computed tomography (CT) procedures are carried out globally, increasing annually by 3%-4%.
  • The dynamic CT industry involves many participants introducing technological innovations frequently to match the rapidly evolving needs of clinicians, radiologists, and technologists.
  • The COVID-19 pandemic further resulted in the postponement of elective surgeries, which took a toll on patient footfall in radiology and affected CT modality.

Global Diagnostic/Medical Imaging Market (2020 to 2026) - Featuring Fujifilm Visual Sonics, Siemens Healthineers and PerkinElmer Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 22, 2021
Health, Other Health, Medicine, Radiology, Medical physics, Medical imaging, Health care, Applied sciences, Image processing, Nuclear medicine, Single-photon emission computed tomography, Magnetic resonance imaging, CT scan, Tomography

Globally, Medical imaging is used to diagnose and treat disease and expose internal structures concealed by the skin and bones.

Key Points: 
  • Globally, Medical imaging is used to diagnose and treat disease and expose internal structures concealed by the skin and bones.
  • Global Diagnostic Imaging Market primarily focuses on creating images of the body, organs, and other internal structures, providing products like X-ray Devices, Computed Tomography, MRI equipment, Ultrasound, and Nuclear Imaging (PET / SPECT) Systems.
  • The COVID-19 pandemic, which occurred in the first days of 2020, has had a significant impact on the Global Diagnostic Imaging Market.
  • High cost of equipment, increasing regulatory burden and declining reimbursement, limitations associated with standalone systems are some reasons restricting the Global Diagnostic Imaging Market.

MeVX™ High Energy Computed Tomography X-Ray Solutions

Retrieved on: 
Thursday, July 15, 2021
Radiation, Radiography, Electromagnetic radiation, Medicine, Medical imaging, Digital radiography, X-ray, CT scan, Tomography, Industrial radiography, Imaging phantom

ROGERS, Minn., July 15, 2021 /PRNewswire/ -- North Star Imaging introduces a new range of High Energy X-ray systems that are available in 3, 6 and 9 Million Electron Volts.

Key Points: 
  • ROGERS, Minn., July 15, 2021 /PRNewswire/ -- North Star Imaging introduces a new range of High Energy X-ray systems that are available in 3, 6 and 9 Million Electron Volts.
  • Timothy Lebens, Global Sales Director NSI says: "The MeVX line answers the need for higher energy X-ray inspection to deeply penetrate, dense parts, that cannot be scanned using standard, lower energy, X-ray equipment.
  • Use of a 3, 6 or a 9 MeVX is a huge time saving solution, especially for aerospace, defense, automotive and other emerging technologies where speed and superior, high resolution images are required for mission critical parts."
  • North Star Imaging manufactures industrial 2D Digital Radiography, 3D Computed Tomography (CT) and High Energy X-ray equipment and provides as-needed X-ray Inspection services.